Ralf Kronenwett
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 46
- Cancer Genomics and Diagnostics 14
- Oncology top 1%
- HER2/EGFR in Cancer Research 22
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 13
- Immunology top 2%
- Immunotherapy and Immune Responses 14
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 11
-
- Advanced Breast Cancer Therapies 26
-
- RNA Interference and Gene Delivery 13
- Co-authors
- Rainer HaasCarsten DenkertManfred DietelBerit MüllerSibylle LoiblSilvia Darb‐EsfahaniGϋnter von MinckwitzWilko Weichert
- Cited by
- Cancer ResearchOncologyHematology
- Journals
- Nucleic Acids Research (1 paper)Journal of Clinical Oncology (15 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Ralf Kronenwett
128 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 1.8k
- Oncology 2.6k
- Hematology 831
- Immunology 1.1k
- Genetics 383
Countries citing papers authored by Ralf Kronenwett
This map shows the geographic impact of Ralf Kronenwett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Kronenwett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Kronenwett more than expected).
Fields of papers citing papers by Ralf Kronenwett
This network shows the impact of papers produced by Ralf Kronenwett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Kronenwett. The network helps show where Ralf Kronenwett may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ralf Kronenwett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2020 | 62 | |
| 3 | 2019 | 57 | |
| 4 | 2018 | 8 | |
| 5 | 2018 | 204 | |
| 6 | 2016 | 152 | |
| 7 | Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial. | 2015 | 6 |
| 8 | 2014 | 107 | |
| 9 | 2013 | 235 | |
| 10 | 2012 | 0 | |
| 11 | 2012 | 13 | |
| 12 | 2012 | 129 | |
| 13 | 2012 | 19 | |
| 14 | 2012 | 25 | |
| 15 | 2011 | 61 | |
| 16 | 2010 | 47 | |
| 17 | 2010 | 28 | |
| 18 | 2005 | 39 | |
| 19 | 2004 | 68 | |
| 20 | 2003 | 10 |
About Ralf Kronenwett
Ralf Kronenwett is a scholar working on Cancer Research, Hematology and Oncology, having authored 131 papers that have together received 5.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (46 papers), Advanced Breast Cancer Therapies (26 papers), HER2/EGFR in Cancer Research (22 papers), Immunotherapy and Immune Responses (14 papers), Cancer Genomics and Diagnostics (14 papers), RNA Interference and Gene Delivery (13 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (2.6k citations) and Hematology (831 citations). Ralf Kronenwett has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Rainer Haas, Carsten Denkert, Manfred Dietel, Berit Müller, Sibylle Loibl, Silvia Darb‐Esfahani, Gϋnter von Minckwitz, Wilko Weichert, Knut Engels and Christine Solbach. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.